GlassScriptPhysician profile
Emad Ghaly
NPI 1285612119
$985.01
in general payments reported to CMS, 2019-2025
10 companies · $60.82 in 2025
The $60.82 reported for 2025 was less than what a typical Neonatal-Perinatal Medicine provider received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $300 · 2021: $119 · 2022: $125 · 2023: $80.70 · 2024: $152 · 2025: $60.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicines360 | $300.00 | 2020 | |
| Chiesi USA, INC. | $135.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2022 | |
| Fresenius Kabi USA, LLC | $125.00 | 2024 | Smoflipid |
| Global Blood Therapeutics, INC. | $118.61 | 2021 | |
| Sanofi Pasteur INC. | $67.23 | 2024-2025 | |
| Genzyme Corporation | $57.10 | 2023 | |
| Biomarin Pharmaceutical INC. | $23.60 | 2023 | Voxzogo 1.2mg |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.86 | 2025 | Lifevest |
| Edwards Lifesciences Corporation | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Ghaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.